B+
Bull case
25%
Probability
Target price
$140.00
Analysis reference price unavailable
Analysis 2026-10-01 · RankAlpha Sentiment Codex
ADUS
Addus HomeCareCNasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
Current thesis
Q2 growth, higher adjusted EBITDA and operating cash flow provide an operating base for the proposed AccentCare expansion. If the transaction closes and management's anticipated accretion materializes without significant integration costs, earnings capacity could exceed the base scenario.
Posture
Mixed
Lead driver
Value
What changed
Next scheduled catalyst: earnings 2026-11-03 · AMC.
What can break
Addus expects to fund the acquisition with cash and its revolver, creating financing-cost and balance-sheet sensitivity. [#PR-2026-09-14]
Momentum
69
Value
64
Sentiment
46
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $122.00 · Bull $140.00 · Bear $88.00Analysis 2026-10-01; returns require an exact persisted reference.
Earnings
2026-11-03 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-30 • Vendor: Data Vendor v1
Scores
As of 2026-10-30 • Model: HYBRID_IC_RP
AI Memo
As of 2026-10-01 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-10-30
Investment thesis
As of 2026-10-30
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-30. Definitions
Supporting evidence
What
Grade C · Mixed
Confidence Medium · Net Neutral
Target $134.08
Why
Momentum69 · Δ7d +17.9
Value64 · Δ7d -0.4
Sentiment46 · Δ7d -0.2
So what
Balanced signals (Net Neutral). Wait for confirmation before sizing up.
Confirming evidence
- • Next scheduled catalyst: earnings 2026-11-03 · AMC.
- • Value remains the lead driver in the composite, 7D delta -0.4.
Contradictions & invalidation
- • Addus expects to fund the acquisition with cash and its revolver, creating financing-cost and balance-sheet sensitivity. [#PR-2026-09-14]
- • Integration costs or weaker-than-expected acquired margins could prevent anticipated accretion. [#PR-2026-09-14]
- • Regulatory delay, integration expense, wage or reimbursement pressure, and revolver-funded acquisition costs could erode the expected benefit.
Catalyst clock
2026-11-03 · AMC
Organic growth and cash-generation validation
Lead driver: Value · See fundamentals
Momentum
69
8% active weight
Current posture
7d trendImproving
Δ7d
+17.9
Δ21d
+23.0
Value
64
47% active weight
Current posture
7d trendFlat
Δ7d
-0.4
Δ21d
-1.1
Sentiment
46
45% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
-12.8
Why this grade
Composite grade C. Momentum 68.6 / Value 63.5 / Sentiment 46.4
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-10-01. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$122.00
Analysis reference price unavailable
Analysis 2026-10-01 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$88.00
Analysis reference price unavailable
Analysis 2026-10-01 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-10-30
Fundamentals (TTM)
As of 2026-10-30
Market Cap
$2.34B
Beta
0.91
Shares Out
18.67M
P/E (TTM)
23.5
P/S (TTM)
1.50
P/FCF (TTM)
21.02
Rev YoY
+8.0%
EPS YoY
+24.2%
Gross Margin
+31.2%
Op Margin
+10.9%
Net Debt
$89.75M
Current Ratio
1.69
As of 2026-10-30 • Updated nightlySource: Internal modelMethods & Data